Abstract |
The MtT/E and MtT/S cells have been established from a mammotrophic pituitary tumor, and postulated to be progenitor and premature growth hormone (GH) cells, respectively. The difference in the regulation of GH and GH-releasing hormone ( GHRH) receptor gene transcription in relation to the developmental stage of GH cells were examined in these two cell lines. In MtT/S cells, triiodothyronine (T3), all-trans retinoic acid (RA) and 9-cis retinoic acid (9cRA) stimulated GH promoter activity but dexamethasone (DEX) did not. On the other hand, DEX stimulated GHRH-receptor promoter alone. T3, RA and 9cRA showed little effect alone but each of them augmented the effect of DEX when used together with DEX. In MtT/E cells, DEX, RA and 9cRA showed similar effect as observed in MtT/S cells on both GH and GHRH-receptor promoter activity. However, T3 neither stimulated GH promoter activity nor augmented the DEX-induced GHRH-receptor gene transcription in MtT/E cells. RT-PCR analyses revealed that both cell types expressed TRalpha1, TRbeta1 and TRalpha2, but expression of TRbeta2, a pituitary specific isoform of TR, was only detected in MtT/S cells. However, the deficiency of TRbeta2 for its own sake does not appear to be a reason why T3 action was not observed in MtT/E cells, because co-transfection of expression plasmids for TRbeta2 and RXRalpha failed in conferring on the cells an ability to respond to T3 by increased GH or GHRH-receptor promoter activity. These results suggest that the acquisition of mechanisms responsible for the regulation of GH or GHRH-receptor transcription by T3 may be involved in the process of functional development of GH cells.
|
Authors | Haruo Nogami, Yoshiki Hiraoka, Kinji Inoue, Sadakazu Aiso, Setsuji Hisano |
Journal | Neuroendocrinology
(Neuroendocrinology)
Vol. 84
Issue 1
Pg. 31-41
( 2006)
ISSN: 0028-3835 [Print] Switzerland |
PMID | 17090972
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright 2006 S. Karger AG, Basel. |
Chemical References |
- Receptors, Neuropeptide
- Receptors, Pituitary Hormone-Regulating Hormone
- Receptors, Somatotropin
- Triiodothyronine
- 9,13-retinoic acid
- Tretinoin
- Growth Hormone
- somatotropin releasing hormone receptor
|
Topics |
- Animals
- COS Cells
- Cell Line, Tumor
- Chlorocebus aethiops
- Gene Expression Regulation
(drug effects)
- Gene Expression Regulation, Neoplastic
- Growth Hormone
(metabolism)
- Pituitary Neoplasms
(genetics, metabolism, pathology)
- Promoter Regions, Genetic
(genetics)
- Rats
- Receptors, Neuropeptide
(genetics, metabolism)
- Receptors, Pituitary Hormone-Regulating Hormone
(genetics, metabolism)
- Receptors, Somatotropin
(genetics, metabolism)
- Tretinoin
(analogs & derivatives, pharmacology)
- Triiodothyronine
(pharmacology)
|